Compugen Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$2.14

-0.02 (-0.93%)

As of Jun 30, 10:28 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +2,071.0% upside

Low Target $33.82

Average Target $46.46

High Target $60.35

Current Price $2.14

Current
$2.14

Target
$46.46

$33.82 $46.46 avg $60.35

Scenario Analysis

Bear Case

$33.82

1,480.4%

Low target

Base Case

$46.46

+2,071.0%

Avg target

Bull Case

$60.35

+2,720.1%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$3.24

-33.8% from high

52-Week Low

$1.30

+65.3% from low

Target vs 52W High

$46.46

+1,336.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%